Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25 Leukemia 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Chronic-Phase 6 Gastrointestinal Stromal Tumors 6 Philadelphia Chromosome 3 Neoplasms 3 Hematologic Diseases 3 Myeloproliferative Disorders 2 Melanoma 2 Leukemia, Myeloid 2 Bronchiolitis Obliterans Syndrome 2 Bone Marrow Diseases 2 Blast Crisis 2 Synovitis, Pigmented Villonodular 1 Recurrence 1 Piebaldism 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplastic Processes 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Mastocytosis, Systemic 1 Leukemia, Myeloid, Accelerated Phase 1 Hypereosinophilic Syndrome 1 Glioma 1 Giant Cell Tumor of Tendon Sheath 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Doxorubicin 29 Ifosfamide 19 pazopanib 16 Gemcitabine 15 Cyclophosphamide 13 pembrolizumab 10 Docetaxel 10 Sirolimus 9 Radiotherapy 9 Vincristine 8 Irinotecan 8 Filgrastim 8 Sorafenib 7 Etoposide 7 Bevacizumab 7 temsirolimus 6 eribulin 6 olaratumab 5 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Mesna 5 Magnetic Resonance Spectroscopy 5 tazemetostat 4 Temozolomide 4 Radiation 4 Ipilimumab 4 Dexrazoxane 4 Dactinomycin 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡